Melissa Grimm
Immunology and Microbiology · The Ohio State University
Publications
56
Citations
1,665
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1995
Melissa Grimm's work focuses on how the immune system interacts with tumors, particularly breast and colorectal cancers, including how inflammatory signaling pathways (like NFkB-COX2) can suppress anti-tumor immunity within the tumor microenvironment. Her publications also cover clinical outcomes of chemotherapy treatments in breast cancer and immune-modulating drug combinations aimed at improving cancer treatment responses.
Publication output was low and irregular from 2017-2022, then spiked sharply in 2023 (largely driven by a single multi-part study), before dropping back down in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy
ESMO Open · 2025
- Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆
ESMO Open · 2024
- Data from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 5 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 7 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 1 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 3 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 6 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 4 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 2 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 6 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 4 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 3 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 5 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Supplementary Figure 2 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
2023
- Cancer Research×5
- ESMO Open×2
- Regular and Young Investigator Award Abstracts×2
- British Journal of Cancer×1
- Journal for ImmunoTherapy of Cancer×1
- Alan Y. Hsu
Immunology and Microbiology · Purdue University West Lafayette
- Qing Deng
Immunology and Microbiology · Purdue University West Lafayette
- Gopalkrishna Sreejit
Immunology and Microbiology · The Ohio State University
- Matthias Zeller
Immunology and Microbiology · Purdue University West Lafayette
- Sharmila Alam
Immunology and Microbiology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile